Eine komplette Bewerbung in einer Minute — maßgeschneiderter Lebenslauf und Anschreiben, versandbereit.
Revolution Medicines is seeking an Associate Director, Regulatory Affairs, Europe to lead regulatory strategy and submissions across EU/EEA, UK and Switzerland for oncology programs. You will represent RA on cross-functional teams and interact with EMA/MHRA/Swissmedic to secure timely approvals.
The role requires extensive experience in European regulatory frameworks, strategic problem-solving with health agencies, and strong leadership in fast-paced environments.
Revolution Medicines is a global, commercial-state oncology company dedicated to discovering, developing and delivering innovative medicines for patients with RAS-addicted cancers. Leveraging its differentiated RAS(ON) tri-complex inhibitor platform, the company is advancing a broad, integrated portfolio of oral RAS(ON) inhibitors designed to directly target the active, cancer-driving state of RAS. Founded on rigorous scientific inquiry and a willingness to challenge long-held assumptions, Revolution Medicines is committed to changing the trajectory of disease for patients with RAS-addicted cancers worldwide.
Our people are united by a shared way of working: follow the science, challenge assumptions, act with urgency and hold ourselves to a high standard of rigor—all in service of patients.
As part of our expanding European organization, we seek a strategic and hands-on Associate Director, Regulatory Affairs, Europe who will provide regulatory leadership for designated programs at RevMed.
The candidate will be responsible for the preparation & end-to-end execution of regulatory MAA filings across the EU, EEA, UK and Switzerland for oncology programs, ensuring alignment of the European regulatory strategy with the global and regional company`s objectives.
They will independently represent regulatory affairs on global and regional cross-functional teams, delivering targeted, strategic and actionable regulatory guidance for oncology programs across one or more therapeutic areas.
The candidate must have a thorough understanding of oncology drug development, applicable European regulations and will be supporting engagement with health authorities including the EMA/MHRA/Swissmedic ensuring successful regulatory outcomes.
The role will report to the Director, Regulatory Affairs, Europe.
Revolution Medicines takes protection and security of personal data very seriously and respects your right to privacy while using our website and when contacting us by email or phone. We will only collect, process and use any personal data that you provide to us in accordance with our CCPA Notice and Privacy Policy. For additional information, please contact privacy@revmed.com.
#LI-Hybrid #LI-LO1